Department of Radiation Oncology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences& Peking Union Medical College,Beijing 100730,China
Abstract： Objective To determine the peripheral dose (PD) of a Trilogy accelerator under different conditions and the feasibility of PD measurement using the semiconductor diode ionization chamber. Methods In a solid water phantom, a CC13 air-filled ionization chamber and a semiconductor diode ionization chamber were used for PD measurements with different distances (13 measurement locations within 1-31 cm), depth (3, 5, 15 cm), field sizes (10, 20, 30 cm), wedge (W15, W45, VW15, VW45), and beam energy (6, 18 MV). The relationship of PD with PDleakage and PDscatter was determined by removing the scatter phantom. Simulating the patients with cervical cancer undergoing radiotherapy, a CIRS phantom received volumetric modulated arc therapy (VMAT), step-shoot intensity-modulated radiotherapy (IMRT), and sliding-window IMRT to measure PDs of the breast, thyroid, and lens. All the data were normalized to the isocenter. Results PD was gradually reduced with the increase in distance (13.41% at 1 cm from the edge to 0.25% at 31 cm from the edge). With a fixed distance from the edge of the radiation field, there was no significant difference in PD between different depths. A radiation field with a size of 30 cm had a PD about two-fold higher than that with a size of 10 cm. PD increased with the increase in the physical wedge angle and increased by 1% compared with the open field;PD decreased with the increase in the virtual wedge angle and decreased by 2-3% compared with the open field. PD decayed from 13.35% at 1 cm to 0.23% at 31 cm under 6 MV X-ray and from 11.06% at 1 cm to 0.20% at 31 cm under 18 MV X-ray. Dscatter was dominant in the regions close to the edge of radiation field and decreased from 62.45% at 1 cm to 5.71% at 25 cm. In all measurements under 6 MV X-ray, the maximum proportion difference between CC13 ionization chamber and diode ionization chamber was less than 1%. PDs of the breast, thyroid, and lens were 6.72, 2.90, and 2.37 mGy in VMAT mode, 7.39, 4.05, and 2.48 mGy in step-shoot IMRT mode, and 9.17, 4.61, and 3.21 mGy in sliding-window IMRT mode, respectively. Conclusions For the measurement of PDs, the CC13 air-filled ionization chamber and semiconductor diode ionization chamber have good consistency and feasibility under 6 MV X-ray. In clinical practice, the understanding of the relationship of PD with different radiation conditions helps to reduce the doses to organs at risk. Shielding and protective techniques can further reduce dose deposition.
Yang Bo,Pang Tingtian,Sun Xiansong et al. Peripheral dosimetry of a Trilogy accelerator[J]. Chinese Journal of Radiation Oncology, 2016, 25(10): 1108-1112.
[1] Lissner S,Schubert K,Wiezorek T,et al. Investigations of peripheral dose for helical tomotherapy[J].Z Med Phys,2013,23(4):324-331.DOI:10.1016/j.zemedi.2013.06.006. [2] D’Agostino E,Bogaerts R,Defraene G,et al. Peripheral doses in radiotherapy:a comparison between IMRT,VMAT and Tomotherapy[J].Radiat Meas,2013,57:62-67.DOI:10.1016/j.radmeas.2013.04.016. [3] Richter E,Feyerabend T.Grundlagen der strahlentherapie[M].Berlin Heidelberg:Springer-Verlag,2002.DOI:10.1007/978-3-642-56245-7. [4] D rr W,Herrmann T.Second primary tumors after radiotherapy for malignancies:treatment-related parameters[J].Strahlenther Onkol,2002,178(7):357-362.DOI:10.1007/s00066-002-0951-6. [5] 杨波,庞廷田,刘峡,等.HT在宫颈癌术后盆腔放疗的优势探讨[J].中华放射肿瘤学杂志,2014,23(6):523-526.DOI:10.3760/cma.j.issn.1004-4221.2014.06.017. Yang B,Pang TT,Liu X,et al. Treatment and dosimetry advantage between FF-IMRT,VMAT,and HT in cervix uteri radiotherapy[J].Chin J Radiat Oncol,2014,23(6):523-526.DOI:10.3760/cma.j.issn.1004-4221.2014.06.017. [6] Annamalai G,Velayudham R.Comparison of peripheral dose measurements using Ionization chamber and MOSFET detector[J].Rep Pract Oncol Radiother,2009,14(5):176-183.DOI:10.1016/S1507-1367(10)60033-8. [7] Balasubramanian R,Sellakumar P,Bilimagga RS,et al. Measurements of peripheral dose for multileaf collimator based linear accelerator[J].Rep Pract Oncol Radiother,2006,11(6):281-285.DOI:10.1016/S1507-1367(06)71073-2. [8] Stern RL.Peripheral dose from a linear accelerator equipped with multileaf collimation[J].Med Phys,1999,26(4):559-563.DOI:10.1118/1.598557. [9] Scrimger J,Kolitsi Z.Scattered radiation from beam modifiers used with megavoltage therapy units[J].Radiology,1979,130(1):233-236.DOI:10.1148/130.1.233. [10] Svensson GK,Kase KR,Chin LM,et al. Dose to the opposite breast as a result of primary therapy for carcinoma of breast[J].Int J Radiat Oncol Biol Phys,1981,7(9):1209.DOI:10.1016/0360-3016(81)90515-0. [11] 胡逸民.肿瘤放射物理学[M].北京.原子能出版社,1999. Hu YM.Tumor radiation physics[M].Beijing:Atomic Energy Press,1999. [12] Wiezorek T,Schwahofer A,Schubert K.The influence of different IMRT techniques on the peripheral dose[J].Strahlenther Onkol,2009,185(10):696-702.DOI:10.1007/s00066-009-2005-9. [13] Fraass BA,van de Geijn J.Peripheral dose from megavolt beams[J].Med Phys,1983,10(6):809-818.DOI:10.1118/1.595359. [14] Jia MX,Zhang X,Yin C,et al. Peripheral dose measurements in cervical cancer radiotherapy:a comparison of volumetric modulated arc therapy and step-and-shoot IMRT techniques[J].Radiat Oncol,2014,9(1):61.DOI:10.1186/1748-717X-9-61.
2016, Vol. 25 
